APA (7th ed.) Citation

CM, d. M., JM, S., FJG, v. A., C, M., PJ, v. D., PJ, N., . . . TJA, v. N. (2026). Impact of axillary disease extent defined by baseline 18F-FDG PET/CT on the accuracy of axillary surgical staging after neoadjuvant systemic therapy in clinically node-positive breast cancer. Breast (Edinburgh, Scotland), 86, 104718. https://doi.org/10.1016/j.breast.2026.104718

Chicago Style (17th ed.) Citation

CM, de Mooij, et al. "Impact of Axillary Disease Extent Defined by Baseline 18F-FDG PET/CT on the Accuracy of Axillary Surgical Staging After Neoadjuvant Systemic Therapy in Clinically Node-positive Breast Cancer." Breast (Edinburgh, Scotland) 86 (2026): 104718. https://doi.org/10.1016/j.breast.2026.104718.

MLA (9th ed.) Citation

CM, de Mooij, et al. "Impact of Axillary Disease Extent Defined by Baseline 18F-FDG PET/CT on the Accuracy of Axillary Surgical Staging After Neoadjuvant Systemic Therapy in Clinically Node-positive Breast Cancer." Breast (Edinburgh, Scotland), vol. 86, 2026, p. 104718, https://doi.org/10.1016/j.breast.2026.104718.